VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Kao Corporation vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Kao Corporation
4452 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Kao Corporation's moat claims, evidence, and risks.
View 4452 analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 60 / 100 for Kao Corporation).
- Segment focus: Kao Corporation has 5 segments (33.5% in Hygiene Living Care Business); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Kao Corporation has 5 moat types across 2 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Kao Corporation
Hygiene Living Care Business
Household & fabric care and sanitary consumer packaged goods
Japan and Asia (with select global brands)
Consumers (retail)
Branded manufacturer
33.5%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Kao Corporation strengths
Novo Nordisk A/S strengths
Segment mix
Kao Corporation segments
Full profile >Hygiene Living Care Business
Oligopoly
Health Beauty Care Business
Competitive
Cosmetics Business
Competitive
Business Connected Business
Competitive
Chemical Business
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.